Inventor · disambiguated record
Milan Blake
Also filed as: BLAKE MILAN · BLAKE MILAN S · BLAKE MILAN SCOTT
25 granted patents·4 pending applications·472 citations·filing 1986–2014
96Inventor score
Files withBAXTER INT7NORTH AMERICAN VACCINE INC6UNIV ROCKEFELLER4BLAKE LAB INC3BAXTER HEALTHCARE SA2
Top patents by PatentIndex Score
29 records- 0195US6248570B1Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccinesBAXTER INT·Filed 1998·Granted Jun 19, 2001·101 cites·40 claims
- 0292US5439808AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1993·Granted Aug 8, 1995·97 cites·19 claims
- 0390US7758855B2DNA promoters and anthrax vaccinesUS HEALTH·Filed 2006·Granted Jul 20, 2010·10 cites·21 claims
- 0486US7332173B2Group A streptococcal polysaccharide immunogenic compositions and methodsUNIV ROCKEFELLER·Filed 2005·Granted Feb 19, 2008·3 cites·20 claims
- 0582US8247225B2DNA promoters and anthrax vaccinesKOPECKO DENNIS J·Filed 2010·Granted Aug 21, 2012·4 cites·5 claims
- 0682US5879686AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted Mar 9, 1999·35 cites·14 claims
- 0781US6686180B2Method for the production of bacterial toxinsBAXTER INT·Filed 2001·Granted Feb 3, 2004·7 cites·5 claims
- 0881US6013267AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted Jan 11, 2000·31 cites·19 claims
- 0977US7045314B2Method for the production of bacterial toxinsBAXTER HEALTHCARE SA·Filed 2001·Granted May 16, 2006·5 cites·5 claims
- 1077US7018813B2Method for the production of bacterial toxinsBAXTER HEALTHCARE SA·Filed 2003·Granted Mar 28, 2006·4 cites·6 claims
- 1175US6451317B1Immunogenic conjugates comprising a Group B meningococcal porin and an H influenzae polysaccharideBAXTER INT·Filed 1998·Granted Sep 17, 2002·37 cites·9 claims
- 1274US4757134AIgA binding proteinUNIV ROCKEFELLER·Filed 1986·Granted Jul 12, 1988·35 cites·8 claims
- 1370US6613336B2Immunogenic conjugates comprising a group B meningococcal porin and an H. influenzae polysaccharideBAXTER INT·Filed 2002·Granted Sep 2, 2003·1 cites·8 claims
- 1470US5866135AGroup A streptococcal polysaccharide immunogenic compositions and methodsNORTH AMERICAN VACCINE INC·Filed 1994·Granted Feb 2, 1999·32 cites·49 claims
- 1568US5869047AMethods for therapeutically treating immunocomprised personsBLAKE LAB INC·Filed 1996·Granted Feb 9, 1999·18 cites·12 claims
- 1663US6124132AUse of anti-HIV IGA antibodies for producing immunological protection against the human immunodeficiency virusBLAKE LAB INC·Filed 1997·Granted Sep 26, 2000·14 cites·14 claims
- 1760US2014248309A1Dna promoters and anthrax vaccinesGOVERNMENT OF THE U S A AS REPRESENTED BY THE SECRETARY DEPT OF HEALTH & HUMAN S·Filed 2014·Application pending·0 cites
- 1857US7829321B2Method for the production of bacterial toxinsBAXTER INT·Filed 2005·Granted Nov 9, 2010·0 cites·4 claims
- 1955US7790185B2Method for the production of bacterial toxinsBAXTER INT·Filed 2005·Granted Sep 7, 2010·0 cites·5 claims
- 2055US5747287AMethod for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidisNORTH AMERICAN VACCINE INC·Filed 1997·Granted May 5, 1998·17 cites·13 claims
- 2147US6153406AMethod for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type BNORTH AMERICAN VACCINE INC·Filed 1993·Granted Nov 28, 2000·8 cites·41 claims
- 2246US4795702ADiagnostic method for gonorrhea by assay of IgA1 fragmentsIMMUNOGON ASSOCIATES·Filed 1986·Granted Jan 3, 1989·12 cites·23 claims
- 2345US2002058042A1Non-IgA fc binding forms of the Group B streptococcal beta antigensFiled 2001·Application pending·0 cites
- 2443US2001051364A1Procedures for the extraction and isolation of bacterial capsular polysaccharides for use as vaccines or linked to proteins as conjugate vaccinesFiled 2001·Application pending·0 cites
- 2537US2002192205A1Immunogenic compositions of low molecular weight hyaluronic acid and methods to prevent, treat and diagnose infections and diseases caused by group A and group C streptococciFiled 2001·Application pending·0 cites
- 2630US6280738B1Non-IgA Fc binding forms of the group B streptococcal β antigensBAXTER INT·Filed 1997·Granted Aug 28, 2001·1 cites·12 claims
- 2730US5202232AIgA binding proteinUNIV ROCKEFELLER·Filed 1991·Granted Apr 13, 1993·0 cites·4 claims
- 2828US6132959AMethod for early detection of HIV infection in babiesBLAKE LAB INC·Filed 1998·Granted Oct 17, 2000·0 cites·12 claims
- 2920US6664094B1Neisserial vaccine free of immunologically functional PIII or class 4 proteinsUNIV ROCKEFELLER·Filed 1994·Granted Dec 16, 2003·0 cites·24 claims
Join the waitlist — get patent alerts
Get an alert when Milan Blake files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →